279 related articles for article (PubMed ID: 16911852)
41. Risk factors for upper tract recurrence in patients undergoing long-term surveillance for stage ta bladder cancer.
Canales BK; Anderson JK; Premoli J; Slaton JW
J Urol; 2006 Jan; 175(1):74-7. PubMed ID: 16406874
[TBL] [Abstract][Full Text] [Related]
42. The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy.
Li WM; Li CC; Ke HL; Wu WJ; Huang CN; Huang CH
J Urol; 2009 Aug; 182(2):451-8; discussion 458. PubMed ID: 19524962
[TBL] [Abstract][Full Text] [Related]
43. Incidence of local recurrence and port site metastasis after laparoscopic radical nephroureterectomy.
Muntener M; Schaeffer EM; Romero FR; Nielsen ME; Allaf ME; Brito FA; Pavlovich CP; Kavoussi LR; Jarrett TW
Urology; 2007 Nov; 70(5):864-8. PubMed ID: 18068440
[TBL] [Abstract][Full Text] [Related]
44. Comparative study of ureteral stripping versus open ureterectomy for nephroureterectomy in patients with transitional carcinoma of the renal pelvis.
Saika T; Nishiguchi J; Tsushima T; Nasu Y; Nagai A; Miyaji Y; Maki Y; Akaeda T; Saegusa M; Kumon H;
Urology; 2004 May; 63(5):848-52. PubMed ID: 15134963
[TBL] [Abstract][Full Text] [Related]
45. Upper urinary tract recurrence following radical cystectomy for bladder cancer.
Furukawa J; Miyake H; Hara I; Takenaka A; Fujisawa M
Int J Urol; 2007 Jun; 14(6):496-9. PubMed ID: 17593092
[TBL] [Abstract][Full Text] [Related]
46. Impact of diagnostic ureteroscopy on long-term survival in patients with upper tract transitional cell carcinoma.
Hendin BN; Streem SB; Levin HS; Klein EA; Novick AC
J Urol; 1999 Mar; 161(3):783-5. PubMed ID: 10022684
[TBL] [Abstract][Full Text] [Related]
47. Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival.
Brausi MA; Gavioli M; De Luca G; Verrini G; Peracchia G; Simonini G; Viola M
Eur Urol; 2007 Nov; 52(5):1414-8. PubMed ID: 17507148
[TBL] [Abstract][Full Text] [Related]
48. Office-based surveillance ureteroscopy after endoscopic treatment of transitional cell carcinoma: technique and clinical outcome.
Reisiger K; Hruby G; Clayman RV; Landman J
Urology; 2007 Aug; 70(2):263-6. PubMed ID: 17826486
[TBL] [Abstract][Full Text] [Related]
49. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
[TBL] [Abstract][Full Text] [Related]
50. Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract.
Novara G; De Marco V; Dalpiaz O; Gottardo F; Bouygues V; Galfano A; Martignoni G; Patard JJ; Artibani W; Ficarra V
BJU Int; 2008 Jun; 101(11):1368-74. PubMed ID: 18241252
[TBL] [Abstract][Full Text] [Related]
51. Upper urinary tract recurrence after radical cystectomy for bladder cancer--who is at risk?
Volkmer BG; Schnoeller T; Kuefer R; Gust K; Finter F; Hautmann RE
J Urol; 2009 Dec; 182(6):2632-7. PubMed ID: 19836794
[TBL] [Abstract][Full Text] [Related]
52. Stripping technique for endoscopic management of distal ureter during nephroureterectomy: experience of 32 procedures.
Giovansili B; Peyromaure M; Saïghi D; Dayma T; Zerbib M; Debré B
Urology; 2004 Sep; 64(3):448-52; discussion 452. PubMed ID: 15351567
[TBL] [Abstract][Full Text] [Related]
53. Risk factors for intravesical recurrence following urothelial carcinoma of the upper urinary tract: no relationship to the mode of surgery.
Koda S; Mita K; Shigeta M; Usui T
Jpn J Clin Oncol; 2007 Apr; 37(4):296-301. PubMed ID: 17513309
[TBL] [Abstract][Full Text] [Related]
54. Long-term oncologic outcome after laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma.
Muntener M; Nielsen ME; Romero FR; Schaeffer EM; Allaf ME; Brito FA; Pavlovich CP; Kavoussi LR; Jarrett TW
Eur Urol; 2007 Jun; 51(6):1639-44. PubMed ID: 17240038
[TBL] [Abstract][Full Text] [Related]
55. Management of patients with upper urinary tract transitional cell carcinoma.
Raman JD; Scherr DS
Nat Clin Pract Urol; 2007 Aug; 4(8):432-43. PubMed ID: 17673914
[TBL] [Abstract][Full Text] [Related]
56. Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: oncological outcomes at 7 years.
Berger A; Haber GP; Kamoi K; Aron M; Desai MM; Kaouk JH; Gill IS
J Urol; 2008 Sep; 180(3):849-54; discussion 854. PubMed ID: 18635229
[TBL] [Abstract][Full Text] [Related]
57. Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: results of a Belgian retrospective multicentre survey.
Schatteman P; Chatzopoulos C; Assenmacher C; De Visscher L; Jorion JL; Blaze V; Van Cleynenbreugel B; Billiet I; Van der Eecken H; Bollens R; Mottrie A
Eur Urol; 2007 Jun; 51(6):1633-8; discussion 1638. PubMed ID: 17055638
[TBL] [Abstract][Full Text] [Related]
58. Endoluminal resection for sessile neoplasia in the GI tract is associated with a low recurrence rate and a high 5-year survival rate.
Wang AY; Ahmad NA; Zaidman JS; Brensinger CM; Lewis JD; Long WB; Kochman ML; Ginsberg GG
Gastrointest Endosc; 2008 Jul; 68(1):160-9. PubMed ID: 18577483
[TBL] [Abstract][Full Text] [Related]
59. Ta T1 low and intermediate transitional cell carcinoma of the bladder: recurrence rates and the timing of check cystoscopies within the first year.
Guney S; Guney N; Canogullari Z; Ergenekon E
Urol Int; 2008; 80(2):124-8. PubMed ID: 18362479
[TBL] [Abstract][Full Text] [Related]
60. Impact of tumour grade, stage, number and size, smoking habits and sex on the recurrence rate and disease-free interval in patients with transitional cell carcinoma of the bladder.
Raitanen MP; Tammela TL
Ann Chir Gynaecol; 1995; 84(1):37-41. PubMed ID: 7645909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
